Iofina Plc (IOFI)

London
15.75
+0.75(+5.00%)
  • Volume:
    363,571
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    15.55 - 15.55

IOFI Overview

Prev. Close
15
Day's Range
15.55-15.55
Revenue
24.99M
Open
15.75
52 wk Range
10.55-20.5
EPS
0.01
Volume
363,571
Market Cap
30.22M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
953,581
P/E Ratio
11.24
Beta
1.35
1-Year Change
13.21%
Shares Outstanding
191,858,408
Next Earnings Date
22 May 2022
What is your sentiment on Iofina Plc?
or
Market is currently closed. Voting is open during market hours.

Iofina Plc Company Profile

Industry
Chemicals
Sector
Materials
Employees
96

Iofina plc is a holding company. The Company is involved in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Its segments are Iodine and Iodine Derivatives, and Montana. The activities of the Iodine and Iodine Derivatives segment include the production of raw iodine, and the production of iodine derivatives and other non-iodine based chemical derivatives. The Montana segment includes the Atlantis Field project for the exploration and production of natural gas, iodine and water for use in various applications, and the Montana Water Depot project, which includes volumes of water retrieved, stored and shipped to customers in close proximity to be used mainly for fracking. It is also engaged in recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. Its Wellhead Extraction Technology (WET) and WET IOsorb methods enable the co-production of iodine from brine.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuyNeutral
Technical IndicatorsStrong SellBuyStrong BuyStrong SellStrong Buy
SummaryNeutralBuyStrong BuyNeutralBuy
  • 52 week high and heading up a number of positives push it higher
    1
    • easy :) https://www.proactiveinvestors.co.uk/companies/news/961332/iofina-says--our-business-has-been-strong--reporting-record-revenue-and-profit-in-first-half-of-2021-961332.html
      0
      • Higher spot prices for Iodine, increased demand supported by strong economic recovery. Main uses of Iodine is in disinfectants, pharmaceuticals, LCD, Xrays, with no close substitutes! Possible multi-bagger this one.
        1
        • Director dealing. Initial rise quickly depressed.
          1
          • RNS lacking financial specifics so punters ditch the stock, too impatient to wait. Highest volume in UK for ages. Board please note.
            0
            • pops head above parapet.....the start of the comeback. Time for another top-up.
              0
              • Volume increase again though each small surrender halts the inevitable.
                0
                • surprisingly good volume in the first two hours.....on the first trading day of Covid year 2. This year....
                  0
                  • And as it rises, along comes the stalker to sell£100 worth, ensuring it falls back 10%One day Rodders... one day.
                    0
                    • professor Challacombe, King's college London..... iodine may help in the Covid battle.... believes mucous membranes ( always vulnerable) could be protected easily!
                      0
                      • yoyo-ing between 14.50 and 13.25 but the spread discourages trading.... fortunately. Trading might be a very poor choice as it could/should move quite quickly ( eventually).
                        0
                        • great news today . Refinance sorted. 7 year plan. Good terms.
                          0
                          • great news today.
                            0
                            • Rights Issue around 20p??
                              0
                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.